ArticleBMC research notes2026
Cytomorphologic changes in blood erythrocytes, leukocytes, and platelets in dogs progressing through CHOP therapy to treat multicentric lymphoma.
Article in BMC research notes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveChemotherapeutic agents can induce morphologic changes in erythrocytes, leukocytes, and platelets in peripheral circulation. However, the cytomorphologic alterations associated with chemotherapy administration in circulating hemic cells are minimally characterized in dogs. Study objectives were to (1) assess differences in erythrocyte, leukocyte, and platelet morphologies and CBC metrics between healthy matched control dogs and dogs with multicentric lymphoma and (2) evaluate alterations in hemic cell morphology and CBC metrics in dogs with multicentric lymphoma being treated with multiagent CHOP chemotherapy regimen.
resultsDogs with multicentric lymphoma (n = 20) had no differences in frequency and magnitude of hemic cell cytomorphology compared to control dogs (n = 20). However, lymphoma dogs had higher leukocyte, neutrophil, and monocyte counts. As dogs with lymphoma progressed through CHOP therapy, no differences in leukocyte or platelet cytomorphology were observed. The frequency and magnitude of erythrocyte polychromasia and were different between multiple chemotherapy timepoints. No morphologies consistent with dysplastic change were observed for any lineages. Differences in several erythrocyte, leukocyte, and platelet CBC indices were also observed. Atypical cytomorphologic abnormalities in circulating erythrocytes, leukocytes, and platelets, with the exception of leukemic cells, may be infrequent findings in dogs with multicentric lymphoma being treated with CHOP chemotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.